Literature DB >> 14938547

Intranuclear inclusion bodies in cultures of human tissue inoculated with varicella vesicle fluid.

T H WELLER, M B STODDARD.   

Abstract

Entities:  

Keywords:  CHICKENPOX; TISSUE CULTURE

Mesh:

Year:  1952        PMID: 14938547

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  22 in total

1.  CELL-FREE VARICELLA-ZOSTER VIRUS IN TISSUE CULTURE.

Authors:  A E CAUNT; D TAYLOR-ROBINSON
Journal:  J Hyg (Lond)       Date:  1964-12

2.  [VIROLOGICAL AND SEROLOGICAL STUDIES IN HERPES ZOSTER].

Authors:  J SOELTZ-SZOETS
Journal:  Arch Klin Exp Dermatol       Date:  1964-07-03

3.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

4.  [STUDIES WITH THE VARICELLA-HERPES ZOSTER VIRUS].

Authors:  J SOELTZ-SZOETS
Journal:  Arch Klin Exp Dermatol       Date:  1965-03-08

5.  Chickenpox and herpes zoster. 1. Complement fixation studies.

Authors:  D TAYLOR-ROBINSON; A W DOWNIE
Journal:  Br J Exp Pathol       Date:  1959-08

6.  Chickenpox and herpes zoster. III. Tissue culture studies.

Authors:  D TAYLOR-ROBINSON
Journal:  Br J Exp Pathol       Date:  1959-12

7.  The soluble antigens of varicella-zoster virus produced in tissue culture.

Authors:  A E CAUNT; C J RONDLE; A W DOWNIE
Journal:  J Hyg (Lond)       Date:  1961-06

8.  Varicella: report of two fatal cases with necropsy, virus isolation, and serologic studies.

Authors:  W J CHEATHAM; T F DOLAN; J C DOWER; T H WELLER
Journal:  Am J Pathol       Date:  1956 Sep-Oct       Impact factor: 4.307

Review 9.  Herpes zoster and postherpetic neuralgia: past, present and future.

Authors:  Gary J Bennett; C Peter N Watson
Journal:  Pain Res Manag       Date:  2009 Jul-Aug       Impact factor: 3.037

Review 10.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.